|
PSMF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.365600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.604200E-01 |
| Normal-vs-Stage2 |
6.525400E-01 |
| Normal-vs-Stage3 |
2.660200E-01 |
| Normal-vs-Stage4 |
4.911600E-01 |
| Stage1-vs-Stage2 |
6.466000E-01 |
| Stage1-vs-Stage3 |
3.077000E-01 |
| Stage1-vs-Stage4 |
5.037000E-01 |
| Stage2-vs-Stage3 |
2.274000E-01 |
| Stage2-vs-Stage4 |
7.102800E-01 |
| Stage3-vs-Stage4 |
2.649400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.416400E-01 |
| Normal-vs-AfricanAmerican |
7.232400E-01 |
| Normal-vs-Asian |
4.274800E-01 |
| Caucasian-vs-AfricanAmerican |
2.449000E-01 |
| Caucasian-vs-Asian |
4.880600E-01 |
| AfricanAmerican-vs-Asian |
6.540600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.125600E-01 |
| Normal-vs-Female |
1.530280E-02 |
| Male-vs-Female |
1.310310E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.623600E-01 |
| Normal-vs-Extreme_Weight |
9.717400E-01 |
| Normal-vs-Obese |
1.773180E-01 |
| Normal-vs-Extreme_Obese |
2.332800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.099600E-01 |
| Normal_Weight-vs-Obese |
1.883240E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.085400E-01 |
| Extreme_Weight-vs-Obese |
3.004800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.299800E-01 |
| Obese-vs-Extreme_Obese |
1.116240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.604000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.856300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.217800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.606100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.378000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.216600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.285900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.249700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.280300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.588570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.160200E-01 |
| Normal-VS-Type2 PRCC |
6.778300E-02 |
| Normal-VS-KIRP CIMP |
8.335600E-01 |
| Normal-VS-Unclassified PRCC |
1.543790E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.740470E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.540000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.565800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.382600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.223200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.379200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.600000E-01 |
| Normal-vs-N1 |
4.849000E-01 |
| Normal-vs-N2 |
9.334100E-02 |
| N0-vs-N1 |
2.955600E-01 |
| N0-vs-N2 |
7.131200E-01 |
| N1-vs-N2 |
3.822200E-01 |
|
|
